SMTL ID : 5cav.1

EGFR kinase domain with compound 41a

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.73 Å

Oligo State

monomer

Ligands

1 x 4ZQ: (1R)-1-{6-({2-[(3R,4S)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl}amino)-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-imidazo[4,5-c]pyridin-2-yl}ethanol(Non-covalent)

4ZQ.1: 17 residues within 4Å: Chain A: L.25, G.26, F.30, V.33, A.50, K.52, E.69, C.82, T.97, Q.98, L.99, M.100, G.103, C.104, L.151, T.161, D.162 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.25, A:L.151 Hydrogen bonds: A:T.97, A:Q.98, A:M.100, A:C.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heald, R. et al., Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. J.Med.Chem. (2015)

Release Date

2015-10-28

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence